Drug – bio-affecting and body treating compositions – Dentifrices – Ammonia – amine – or derivative thereof
Patent
1998-03-27
1999-11-30
Krass, Frederick
Drug, bio-affecting and body treating compositions
Dentifrices
Ammonia, amine, or derivative thereof
424 49, 424 55, 5142265, 514255, 514352, 514365, 514407, 514411, 514413, 514427, 514428, 514448, 514555, 514900, 514902, A61K 4736
Patent
active
RE0364193
ABSTRACT:
The present invention provides novel methods for prevention or treatment of primary and recurring squamous cell carcinoma of the oral cavity or oropharynx comprising topical administration, to the oral cavity or oropharynx, of an effective amount of an NSAID, especially a composition administering from about 0.001% to about 0.2% ketorolac to the oral cavity, alone or as an adjunct to surgery and/or radiation therapy.
REFERENCES:
patent: 4748174 (1988-05-01), Veronesi
patent: 5464609 (1995-11-01), Kelm et al.
Tanaka, T., et al., Cancer Letters, 48 (1989), pp. 177-182, "Inhibitory Effects of Non-Steroidal Anti-Inflammatory Drugs, Piroxicam and Indomethican on 4-nitroquinoline 1-Oxide-Induced Tongue Carcinogenesis in Male ACI/N Rats".
DeCosse, Jerome J., American Cancer Society, pp. 2550-2553, "Potential for Chemoprevention".
Hirsch, Barry, et al., Arch Otolaryngol--vol. 109, May 1983, pp. 298-301, "Immunostimulation of Patients with Head and Neck Cancer".
Pinto, S., et al., Prostaglandins Leukotrienes and Essential Fatty Acids (1990), pp. 53-57, "Prostaglandins in Squamous Cell Carcinoma of the Larynx: Tumor and Peritumor Synthesis".
Snyderman, Carl H., et al., Otolaryngology--Head and Neck Surgery (1994), pp. 184-196, "Comparison of in vivo and in vitro Prostaglandin E.sub.2 Production By Squamous Cell Carcinoma of the Head and Neck".
Hancock, A. B., Cancer Research 52 (1992), pp. 5575-5589, "Aspirin and the Potential Role of Prostaglandins in Colon Cancer".
Regezi, Joseph, et al., Oral Pathology: Clinical-Pathologic Correlations, Second Edition, pp. 77-88, "Ulcerative Conditions" (1993.
Resman-Targoff, B. H., DICP, The Annals of Pharmacotherapy, vol. 24 (1990), pp. 1098-1104, "Ketorolac: A Parenteral Nonsteroidal Antiflammatory Drug".
Cameron, Deborah J., et al., Cancer vol. 54 (1984), pp. 2403-2408, "The Ability of Macrophages From Head and Neck Cancer Patients to Kill Tumor Cells".
Colacchio, Thomas A., et al., The American Journal of Surgery, vol. 167 (1994), pp. 174-179, "Perioperative Immunomodulation in Cancer Surgery".
Goodwin, James S., Journal of Immunopharmacology, 2(4) (1990), pp. 397-424, "Prostaglandin Synthetase Inhibitors as Immunoadjuvants in the Treatment of Cancer".
Earnest, David L., et al., Journal of Cellular Biochemistry, Supp. 161 (1992), pp. 156-166, "Piroxicam and Other Cyclooxygenase Inhibitors: Potential for Cancer Chemoprevention".
Panje, William R., Arch Otolaryngol, vol. 107 (1981), pp. 658-663, "Regression of Head and Neck Carcinoma with a Prostaglandin-Synthesis Inhibitor".
Krass Frederick
Mohl Douglas C.
Reed T. David
The Procter & Gamble & Company
White Loy M.
LandOfFree
Use of ketorolac for treatment of squamous cell carcinomas of th does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of ketorolac for treatment of squamous cell carcinomas of th, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ketorolac for treatment of squamous cell carcinomas of th will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1656800